Literature DB >> 12887283

Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions.

M L Raffin-Sanson1, Y de Keyzer, X Bertagna.   

Abstract

Proopiomelanocortin (POMC) is the polypeptide precursor of ACTH. First discovered in anterior pituitary corticotroph cells, it has more recently been revealed to have many other physiological aspects. The fine molecular mechanisms of ACTH biosynthesis show that ACTH is but one piece of a puzzle which contains many other peptides. Present in various tIssues, among which are pituitary, hypothalamus, central nervous system and skin, POMC undergoes extensive post-translational processing. This processing is tIssue-specific and generates, depending on the case, various sets of peptides involved in completely diverse biological functions. POMC expressed in corticotroph cells of the pituitary is necessary for adrenal function. Recent developments have shown that POMC-expressing neurons in the brain play a major role in the control of pain and energy homeostasis. Local production of POMC-derived peptides in skin may influence melanogenesis. A still unknown function in the placenta is likely.POMC has become a paradigmatic polypeptide precursor model illustrating the variable roles of a single gene and its various products in different localities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887283     DOI: 10.1530/eje.0.1490079

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  60 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

Review 2.  Diagnosis and treatment of ACTH deficiency.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

3.  Profiling signaling peptides in single mammalian cells using mass spectrometry.

Authors:  Stanislav S Rubakhin; James D Churchill; William T Greenough; Jonathan V Sweedler
Journal:  Anal Chem       Date:  2006-10-15       Impact factor: 6.986

4.  Pituitary development and physiology.

Authors:  Clement C Cheung; Robert H Lustig
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

5.  "patients can have as many gene variants as they damn well please": why contemporary genetics presents us daily with a version of Hickam's dictum.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-05       Impact factor: 5.958

6.  Spontaneous and CRH-Induced Excitability and Calcium Signaling in Mice Corticotrophs Involves Sodium, Calcium, and Cation-Conducting Channels.

Authors:  Hana Zemkova; Melanija Tomić; Marek Kucka; Greti Aguilera; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2016-02-22       Impact factor: 4.736

7.  Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.

Authors:  Nesrin Filiz Basaran; R Levent Buyukuysal; William R Millington; Sinan Cavun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

8.  Enhancer turnover and conserved regulatory function in vertebrate evolution.

Authors:  Sabina Domené; Viviana F Bumaschny; Flávio S J de Souza; Lucía F Franchini; Sofía Nasif; Malcolm J Low; Marcelo Rubinstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

9.  Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.

Authors:  T Tateno; M Kato; Y Tani; T Yoshimoto; Y Oki; Y Hirata
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

10.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.